Print Page   |   Contact Us   |   Report Abuse   |   Sign In   |   Join UPhA
2017 Mid-Year Meeting
Share |

2017 Mid-Year Meeting

Saturday
November 4, 2017
From 8:00am - 5:45pm

 

Embassy Suites Hotel

3524 Market Street
West Valley City, UT 84119

 

Thank you to all those that attended the Mid Year CE Event. The assessments are posted below. Once you submit the assessment for each class, the credit will go onto a report that will be included in the batches we submit to national.
The first batch will be reported on November 17, 2017.

 

Agenda and Education Topics: 

Diabetes: AACE/ACE vs ADA - The Clinical Dilemma of Conflicting Guidelines Presenter: Tim Drake, PharmD, MBA, BCPS (ACPE #0119-0000-17-030-L01-P/T) Assessment

 Handout
Handout2 
Objectives:

-Identify 3 areas where the ADA guidelines differ from the ACE/AACE guidelines in the treatment of type 2 diabetes. 

-Identify the correct medication and dose to lower ASCVD risk in a patient with diabetes.

-Develop a plan to initiate basal insulin in a patient with type 2 diabetes.

Keeping My License in Good Standing
Presenters: Lynn Hooper, Roger Fitzpatrick, Jeff Gatzemeier (ACPE #0119-0000-17-024-L03-P/T) Assessment

 Handout
Handout2
Objectives:
- Identify the most common investigative and audit findings in a pharmacy.

- Describe how to prepare for an audit.

- Identify proper intern and technician in training ratios.

- Identify additional requirements pharmacies that provide delivery and mail prescriptions.

- Identify DEA inventory control vs  annual state inventory.  

Utah CPESN Update
Presenter: Janet Norman, RPh (ACPE# 0119-0000-17-023-L04-P/T) Assessment   Handout
Objectives:
- Describe the changing climate of health care and how this affects future reimbursement and practice opportunities

- Identify the rationale behind the formation of a CPESN on a national and local level

- Discuss the basic structure and services offered by the Utah CPESN

- Identify the current and future activity of the Utah CPESN

Role of Pharmacy in Opioids Overdose Prevention
Presenter: Christine Jacobsen, RPh (ACPE #0119-0000-026-L01-P/T) Assessment   Handout
Objectives:
- Describe the need to address opioid related overdose in the state of Utah

- Describe the importance of training pharmacists, pharmacy technicians, and pharmacy clerks

- Describe Naloxone and how it works

The COPD Solution
Presenter: Dawn Fielding, RCP AE-C (ACPE #0119-0000-17-027-L01-P/T) Assessment   Handout
Objectives:
- Identify the COPD the disease process

- Describe the medications used to treat Asthma - What type and when to use them

- Identify what medications are used to treat COPD?

- Identify the stages of COPD – how is it measured?

- Identify the symptoms of COPD and Asthma

- Describe how to help the patients you come face to face with regarding COPD and Asthma

Infectious Disease: HIV Pre-exposure Prophylaxis
Presenter: Aesha Drozdowski, PharmD, BCPS (ACPE #0119-0000-17-028-L01-P/T) Assessment   Handout
 
Objectives:

- Identify the need for additional HIV Prevention Methods

- Describe the evidence supporting the safety and efficacy of antiretroviral (ARV) prophylaxis

- Identify indications for PrEP

- Describe how to provide and discontinue PrEP and how to address special clinical considerations

- Identify how to reduce HIV risk behaviors in patients

- Identify financial issues related to PrEP

New Drugs & Therapies Update
Presenter: Nicholas Cox, PharmD (ACPE #0119-0000-17-029-L01-P/T) Assessment   Handout
Pharmacy Objectives:
-Describe the indication(s), mechanism of action, evidence for approval, and key counseling points for new drugs/biologics approved by the U.S. Food and Drug Administration (FDA) over the past year

-Assess the potential role in therapy for new drugs/biologics approved by the FDA over the past year

-Compare and contrast new drugs/biologics approved by the FDA over the past year to previously existing therapies

-Explain the factors impacting trends in the number of new drug/biologic approvals

Technician Objectives:
-List the brand/generic names and indication(s) of
new drugs/biologics approved by the U.S. Food and Drug Administration (FDA) over the past year
-Define the following terms: novel drug, first-in-class drug, rare/orphan disease drugs
- Explain the factors impacting trends in the number of drug/biologic approvals  

          

Credit Issued 

All credit will be issued 60 days following the event. 

CPE Monitor 

CPE Monitor is a collaborative system used by ACPE, the National Association of Boards of Pharmacy (NABP), and ACPE-accredited providers for all pharmacists and technicians to record and track their CPE credits. If you have not obtained your NABP e-Profile ID number, go to www.nabp.net/programs/cpe-monitor/cpe-monitor- service/ to set up your e-Profile. If you have any questions about this service or your number, please contact NABP customer support at 847-391-4406, Monday to Friday between 9:00 pm and 5:00 pm CT. 

Target Audience 

UPhA education sessions are designed for pharmacists and pharmacy technicians from all practice settings. 

Courses appropriate for pharmacist participation are designated by an ACPE universal activity number ending in the letter "P.” 

Courses appropriate for pharmacy technician participation are designated by an ACPE universal activity number ending in the letter "T.”
Review the ACPE information for each session to determine the amount of credit offered. 

Session Handouts 

To help preserve our natural resources, UPhA education sessions are paperless. However, to offer participants an enduring reference to the education content, the majority of the presentation materials are available at www.UPhA.com. These presentations will remain online until December 31, 2017. 

Activity Type

All activity types at this meeting are Knowledge Based activities.

Partial Credit 

UPhA does not offer partial credit for any CPE activity. 

Learning Objectives 

Learning objectives for all CPE sessions are provided here, on the UPhA website, www.UPhA.com, in the program event guide, and are provided at the beginning of each session. 

Disclosures 

Financial support for individual education sessions is indicated on handouts and noted at the beginning of each education session. Faculty disclosures are provided upon request. 

CPE Requirements 

To earn CPE credit for a session accredited by UPhA, participants must actively participate in the entire session, submit an attendance code, complete an activity evaluation, and "claim” your credit using the online CPE submission site. Proof of your CPE credit will be available to you on CPE Monitor. UPhA no longer issues paper statements of credit. Credit will not be issued past 60 days of the event. 

• You may record your CPE credit online at www.UPhA.com after the meeting until December 31, 2017. 

• You will need your upha.com username and password. If you need this information you can request it at the meeting registration desk or using the forgot password option on www.UPhA.com

• You will need your NABP e-Profile ID to allow the CPE credit to be transferred to the CPE Monitor system. You will need an attendance code for each session that you attended. These codes will be provided to you in each session. 

• You can print your CPE transcript directly from CPE Monitor. Individual statements of credit from UPhA are not available. 

Grievance Policy 

Should any attendee of an approved CPE session be dissatisfied with the quality of the activity, a request in writing must be submitted to the UPhA Education Department at upha@upha.com within 5 days of the conclusion of the session. 

 

Utah Pharmacists Association is on probation as an accredited provider of continuing pharmacy education by the Accreditation Council for Pharmacy Education.  

 
Community Search
Sign In
Sign In securely